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The adenylate cyclase complex is a ubiquitous ‘second-messenger’ system mediating the actions of hormones and neurotrans- 
mitters. Its presence but not its phys~olo~cal control and function had previously been established in the cochlea. 
In this study, the hormonal stimulation of adenylate cyclase activity of the stria vascularis of the CBA mouse was characterized. In 
the presence of the regulatory nucieotide, GTP. the enzyme was stimulated by isoproterenol and epinephrine with a half-maximal 
effect at about 10 pM and the stimulation was blocked by propranolol. This profile is consistent with the presence of adrenergic 
&receptors on the strial enzyme complex. Hormones and neuromodulators preferring other receptor subtypes were ineffective; the 
non-specific stimulator, forskolin, activated the enzyme. The finding that potential hormonal effecters of water and ion transport 
including vasopressin were inactive may be significant with regard to the physiological role of strial adenylate cyclase. 
adenylate cyclase, stria vascularis. adrenergic receptors, epinephrine, forskolin 
introduction 
The presence of adenylate cyclase in the inner 
ear is firmly established. The membrane-bound 
enzyme is distributed in all labyrinthine structures 
and shows highest activity in ,stria vascularis 
(Ahlstriim et al., 1975; Bagger-Sjiibtick et al., 1980; 
Zajic et al., 1983). Adenylate cyclase is part of a 
second-messenger system which may mediate the 
effects of hormones and neurotransmitters on a 
wide variety of cellular reactions. 
The important issue of the hormonal regulation 
of adenylate cyclase in the inner ear was first 
addressed by Zenner and Zenner (1979) who re- 
ported that an enzyme preparation from the whole 
cochlea was responsive to isoproterenol and 
vasopressin. Although the site of action of these 
agonists remained open, this finding promoted the 
discussion of the involvement of the strial enzyme 
in cochlear ion and fluid balance, a question as yet 
unresolved (for a review, see Schacht, 1982). 
We have previously determined adenylate 
cyclase in iabyrinthine tissues (Bagger-Sjob;ick et 
al., 1980) and localized its activity in stria vascul- 
aris to the contraluminal infoldings of the margi- 
nal cells (Zajic et al., 1983). The present study was 
designed to define the hormonal regulation of the 
strial adenylate cyclase. 
Methods 
Stria vascularis was obtained from CBA mice 
(20-25 g: Jackson Laboratories, Bar Harbor, ME). 
Inner ears were dissected in cold 300 mM 
sucrose/5 mM Tris-acetate, pH 7.4. Stria were 
collected in a glass homogenizer in 25 mM Tris- 
acetate, pH 7.4, with 1 mM dithioerythritol (DTE). 
Homogenization (tissue from two ears per each 
100 ~1) was carried out with a tenon pestle: 5 
strokes by hand were followed by 15 s of mechani- 
cal rotation of the pestle at approximately 600 rpm. 
The homogenate was centrifuged for 5 min at 
12 000 X g and the supernatant discarded. The pel- 
let was resuspended in cold homogenization buffer 
to the initial volume. 
Incubations for the formation of cyclic AMP 
were performed at 36°C in 25 mM Tris-acetate. 
5 mM MgC12, 0.5 mM ATP, 0.02 mM GTP. 
0.2 mM isobutylmethylxanthine (as phos- 
phodiesterase inhibitor), 1 mM DTE, 0.1% bovine 
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serum albumin and 5 mM creatine phosphate/5 
units creatine phosphokinase (as an ATP-regener- 
ating system); final pH, 7.4. Incubations were 
started by the addition of the enzyme preparation 
(approximately 3 pg of protein per assay tube) to 
yield a final volume of 100 ~1. The incubations 
were terminated by the addition of 25 ~1 of 20% 
trichloroacetic acid and centrifuged for IO min at 
1000 x g. Cyclic AMP was isolated from the su- 
pernatant by passage over a small column of 
Dowex 50 (H”) (Steiner, 1974) and analyzed by 
radioimmunoassay (Becton-Dickinson, Orange- 
burg, NY). 
Chemicals were reagent grade. Drugs were 
purchased from Sigma (St. Louis, MO) except 
forskolin which was from 
CA). 
Results 
Cal Biochem (La Jolla, 
After homogenization and centrifugation the 
enzymatic activity was found in the pelleted 
material. This was consistent with previous de- 
scriptions of the cochlear enzyme as membrane-as- 
sociated (Zajic et al., 1983; Zenner and Zenner, 
1979). 
Formation of cyclic AMP was essentially linear 
up to 60 min of incubation (Fig. 1). The addition 
of 0.1 mM ( - )-isopraterenol increased cyclic AMP 
formation by about 100% at all times. A 30 min 
time was chosen for subsequent experiments. The 
presence of guanyl nucleotide elevated enzymatic 
activity and promoted the expression of stimu- 
lation with a maximal effect around 10 PM GTP 
(Fig. 2). The non-hydrolysable GTP analog, 
guanylylimidodiphosphate (GMP-PNP), could 
substitute for GTP and was equipotent to 10 PM 
GTP at about 0.3 PM. Higher concentrations of 
GMP-PNP increased cyclic AMP formation up to 
25-fold (at 10 PM) but the stimulation by isopro- 
terenol was attenuated (21 & 5% stimulation at 10 
to 100 PM vs. 110 h 37% at 0.01-0.3 PM GMP- 
PNP). 
The hormone epinephrine also stimulated CAMP 
formation with a half-maximal effect at 10 PM 
(Fig. 3). The maximal stimulation was somewhat 
less than that achieved with isoproterenol (Table 
I). The P-antagonist propranolol blocked the 
stimulation both by isoproterenol (Table I) and by 
epinephrine (Fig. 3). 
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Figs. 1-4. Effect of time and drug concentrations on the 
formation of cyclic AMP by strial adenylate cyclase. All in- 
cubations were performed with particulate fractions of stria 
vascularis (approx. 3 pg protein/incubation) for 30 min as 
described in Methods with the variations noted below. All 
figures are from single experiments with each determination in 
duplicate. 
Fig. 1. Time-course. 0, controls; 0, +O.l mM isoproterenol. 
Fig. 2. Effect of guanosine 5-triphosphate (GTP). 0, controls; 
0, + 0.1 mM isoproterenol. ‘C’ on the abscissa, control without 
GTP. 
Fig. 3. Effect of (-)-epinephrine. 0, variable concentrations of 
epinephrine as indicated; ‘C’ on the abscissa, control without 
epinephrine. 0, addition of 50 nM propranolol. 
Fig. 4. Effect of forskolin. A forskolin stock solution was 
prepared in ethanol and controls received equivalent amount of 
alcohol (less than 10% of total assay volume). ‘C’ on the 
abscissa, control without forskolin. 
Norepinephrine, a &-agonist, as well as a num- 
ber of selected hormones and neurotransmitters 
did not affect strial adenylate cyclase (Table II). 
Particular attention was paid to vasopressin 
(lysine-vasopressin) which was tested over a 
lOOOO-fold concentration range and assays were 
performed in the absence of guanyl nucleotide, in 
the presence of 0.1 mM dopamine and with homo- 
genates prepared under inclusion of 10 PM phenyl 
TABLE I 
ADRENERGIC CONTROL OF STRIAL ADENYLATE 
CYCLASE 
Particulate fractions from stria vascularis were incubated for 
30 min as described in Methods. Values are means *SE. for 
the number of experiments (n ) indicated. 
Drugs added CAMP formed n 
(0.1 mM) (as % of control) 
None 100 8 
( - )-lsoproterenol 215+12 * 14 
DL-Propranolol 95+ 6 6 
Isoproterenol plus 
propranolol 861 8 6 
( - )-Epinephrine 189kll * 15 
L-Norepinephrine 112* 7 5 
* Differs from control. P < 0.001. 
methylsulfonyl fluoride, a protease inhibitor 
(Zenner and Zenner, 1979). No consistent stimula- 
tion of adenylate cyclase was observed under any 
of these conditions and no dose-response curve 
could be obtained. 
Forskolin, a diterpene activator of adenylate 
cyclase (Seamon et al., 1981), was effective on the 
strial enzyme (Fig. 4). At 100 PM a 4- to 5-fold 
increase of activity was observed consistent with 
the range of stimulation of 2- to 15-fold that has 
been reported for the enzyme from a variety of 
tissues (Seamon et al., 1981). The presence of 
TABLE II 
AGONISTS WITHOUT EFFECT ON STRIAL ADENY- 
LATE CYCLASE 
The following agents were tested for stimulation of strial 
adenylate cyclase as described in Methods. n represents the 
number of incubations in which a drug was tested. Each set of 
experiments included isoproterenol as a positive control. 
Agonist Concentrations tested n 
(ILM) 
L-Norepinephrine 100 4 
Dopamine 100 14 
Histamine 1:lOO 8 
5-Hydroxytryptamine 1;lOO 8 
Vasoactive Intestinal Peptide 0.01-10 8 
Vasopressin 0.01-100 20 
Prostaglandin E, 0.01-100 14 
Parathyroid hormone 1O-6-1 unit 14 
guanine nucleotide was not necessary for the 
expression of the forskolin effect, in agreement 
with observations on adenylate cyclase from rat 
cerebral cortex (Seamon et al., 1981). 
Discussion 
The adenylate cyclase complex serves as an 
important transmembrane signaling mechanism. 
Its activity is controlled by hormones and neuro- 
transmitters that interact with specific receptors on 
the external surface of the plasma membrane. 
Binding to the receptor stimulates adenylate 
cyclase to produce cyclic AMP intracellularly. 
Cyclic AMP, in turn initiates a reaction cascade 
that culminates in the final biological response. In 
addition to the receptor and the catalytic unit. the 
complex contains at least one more component, a 
GTP-binding protein regulating the interaction be- 
tween the hormone receptor and the catalytic sub- 
unit (Lefkowitz et al., 1982). Mediated by this 
system are some of the effects of transmitters such 
as norepinephrine, dopamine, histamine and 5-hy- 
droxytryptamine, of hormones such as epine- 
phrine, vasopressin and glucagon, or of local mod- 
ulators such as prostaglandins. Depending on the 
receptor and tissue involved diverse cellular 
processes are controlled such as glycogenolysis and 
lipolysis, membrane permeabilities and secretion, 
or postsynaptic electrical activity (Schramm and 
Selinger, 1984). 
The present study demonstrates that strial 
adenylate cyclase is under adrenergic control. More 
specifically, the profile of activation, isoproterenol 
> epinephrine > norepinephrine. and the block by 
propranolol are consistent with a regulation via 
&-adrenergic receptors. In contrast to the neuro- 
transmitter-linked junctional fl,-receptors these are 
hormonal extra-junctional receptors, typically 
found in tissues without sympathetic innervation 
(Ariens and Simmonis, 1983). Hormones acting on 
these receptors generally modulate cellular meta- 
bolic activity. 
Tests of selected agonists did not demonstrate 
another hormone-sensitive adenylate cyclase in the 
strial preparation. Dopamine, histamine, 5-hy- 
droxytryptamine, mainly associated with adenylate 
cyclase in neuronal pathways in regions of the 
CNS, were ineffective further providing a control 
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for the specificity of epinephrine. Notably absent 
was a stimulation by vasopressin which has a 
reported effect on adenylate cyclase from the whole 
cochlea. While a number of reasons could explain 
this difference (e.g., animal species; differences in 
enzyme preparation and assay), the simplest argu- 
ment is that a vasopressin-stimulated adenylate 
cyclase is associated with a structure in the cochlea 
other than stria vascularis. This possibility is 
strengthened by the fact that our enzyme prepara- 
tion is sensitive to isoproterenol to about the same 
extent as reported by Zenner and Zenner (1979). 
Vasoactive intestinal peptide (VIP), prostaglandin 
E, (PG E,) and parathormone (PTH) are poten- 
tial effecters of an adenylate cyclase linked to ion 
or water transport: for example, VIP and the 
PGEs increase intestinal fluid and electrolyte 
secretion (Kimberg, 1974). Although not reported 
in detail, both compounds have been suggested to 
be present in the cochlea (Lim et al., 1983; Mat- 
thias, 1983). PTH has a physiological action on the 
kidney affecting the excretion of phosphate, K’. 
Hf and NH: and the tubular reabsorption of 
Ca*+ and Mg*+. None of these agonists was able 
to activate adenylate cyclase in stria vascularis. 
These observations considerably weaken the argu- 
ment that the stria! enzyme is involved in the 
control of endolymphatic ion and fluid balance 
(Schacht, 1982). 
Forskolin, a natural diterpene, is a known 
stimulator of adenylate cyclase in a variety of 
tissues (Seamon et al., 1981). Its action differs 
from that of the hormones in that it activates the 
catalytic subunit of the enzyme directly. It may 
thus be a useful tool for studying the presence of 
adenylate cyclase in tissues in vitro as well as 
histochemically. It may also prove useful in elevat- 
ing intracellular CAMP concentrations to study the 
physiological actions of the adenylate cyclase sys- 
tem regardless of hormonal stimulation. While 
other non-hormonal activators such as NaF and 
guanylylimidodiphosphate stimulate broken cell 
preparations their use in vivo is limited by their 
restricted penetration of the cell membrane. In 
fact, forskolin seems to be an even more powerful 
stimulator of adenylate cyclase in intact cells than 
in broken cell preparations (Seamon et al., 1981). 
Current pharmacological evidence as to the 
physiological role of strial adenylate cyclase is 
insufficient. Electrophysioiogical data after 
cochlear perfusion of LY- or &adrenergic agents 
still remain inconclusive yet generally point to the 
lack of a specific effect (Ahlstrom et al.. 1975: 
Comis and Leng, 1979; Klinke and Evans, 1977; 
Marcus et al., 1982). Endolymphatic application of 
cholera toxin, a stimulant of adenylate cyclase, 
was reported to increase endolymph volume (Feld- 
man and Brusilow, 1976) but cyclic AMP levels in 
cochlear tissues were not significantly altered 
(Thalmann et al., 1982). The current study is the 
first one to characterize the hormonal regulation 
of adenylate cyclase in an individual tissue of the 
inner ear. If we obtain similar information about 
the regulatory mechanisms in other labyrinthine 
structures we may be able to examine the effects of 
adenylate cyclase on the cochlear physiology and 
electrophysiology with the use of tissue-specific 
hormones. 
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